---
title: Machine learning in biomedicine
videoId: xlMTWfkQqbY
---

From: [[lexfridman]] <br/> 

Machine learning is becoming an increasingly vital component in the field of biomedicine, promising to revolutionize the processes of drug discovery and treatment development. Leading experts like Daphne Koller are pioneering its application in the biomedical sector through efforts such as those undertaken at the company Insitro, which she founded to leverage data-driven methods to improve human health <a class="yt-timestamp" data-t="00:00:11">[00:00:11]</a>.

## The Intersection of Machine Learning and Biomedicine

The integration of [[machine_learning_and_ai_in_healthcare | machine learning and artificial intelligence]] with biomedicine presents a transformative approach to understanding and addressing diseases. Machine learning algorithms can sift through vast datasets to find patterns in human health and disease, enabling better understanding and potentially unveiling pathways for effective treatments that are not obvious to human researchers <a class="yt-timestamp" data-t="00:00:18">[00:00:18]</a>.

## Challenges in Curing Diseases

One of the fundamental hurdles in biomedicine is the complexity of diseases. Often, by the time a disease is detected, significant damage may have already occurred, making treatment significantly more challenging. The bold prediction of finding cures for all diseases remains elusive, as many conditions like [[deep_learning_for_cancer_diagnosis_and_treatment | cancer]], Alzheimer's, and schizophrenia are not single diseases but rather manifest as a variety of subtypes requiring distinct approaches <a class="yt-timestamp" data-t="00:03:05">[00:03:05]</a>.

## Stratified Disease Understanding

Machine learning assists in stratifying diseases into their molecular subtypes. By examining the expression levels of genes, researchers can identify distinct disease phenotypes that might respond differently to treatments. This stratification is crucial for developing targeted therapies, which are more effective and carry fewer side effects <a class="yt-timestamp" data-t="00:06:01">[00:06:01]</a>.

## Data Acquisition and Model Training

The effectiveness of machine learning in biomedicine is heavily reliant on the availability and quality of datasets. Traditionally, collecting comprehensive datasets has been a challenge. However, advances in genomics and biomedical data collection have made it possible to generate large-scale, high-quality datasets, which are critical for training robust machine learning models. These datasets enable the prediction of disease progression and response to therapy <a class="yt-timestamp" data-t="00:11:00">[00:11:00]</a>.

## Approaches: Disease in a Dish Model

A novel approach being explored is the 'disease in a dish' model. This method utilizes induced pluripotent stem cells (iPSCs) to create cellular models of diseases. These models provide a platform for testing the effects of drugs at a cellular level, providing insights into potential treatments before clinical trials. The ability to create and study specific diseases in vitro offers a more direct and relevant data source for machine learning applications <a class="yt-timestamp" data-t="00:17:02">[00:17:02]</a>.

## Predictive Models for Drug Discovery

Machine learning's application in predictive modeling aims to understand the biological processes underpinning diseases and to design new drugs that can modify these processes. These predictive models are the backbone of a strategy that seeks to deduce which molecular compounds can best serve as effective therapeutics, thereby streamlining the drug discovery process and potentially reducing the time and cost of bringing new drugs to market <a class="yt-timestamp" data-t="00:20:54">[00:20:54]</a>.

## Challenges and Future Directions

Machine learning in biomedicine still faces significant hurdles, including the reproducibility of results and the translation of findings from in vitro models to in vivo human systems. Nevertheless, as machine learning techniques and data science continue to advance, and as interdisciplinary collaborations grow, the capabilities of machine learning in revolutionizing biomedicine are promising. This evolution supports a hopeful outlook on the impactful role machine learning will play in enhancing human health and unraveling the complex nature of diseases <a class="yt-timestamp" data-t="00:35:31">[00:35:31]</a>.

The journey of machine learning in biomedicine is just beginning, poised at the brink of significant scientific and societal breakthroughs. As more innovative approaches are developed, the potential for machine learning to make substantial inroads into personalized and precision medicine grows, aligning with broader goals across the medical and technological landscapes.